>We identified 34 nonsynonymous SNVs in 17 known CHdriver genes, of which TP53 and DNMT3A were the most frequent. Notably, clone size was small, ranging from 0.10% to 0.95% VAF, and thus did not achieve the technical threshold to be considered as CHIP
and
>Due to the lack of longitudinal samples and small sample size, conclusions regarding the implications of observed lesions remain limited, and further studies are required to assess the penetrance of these clones.
Is that how the rest of you read this, especially those of you who are more expert?